Trump reduces import tariffs on beef, hoping to drive down prices at the meat counter
Ground beef prices have climbed roughly 40% over the past five years, becoming a stubborn inflation pressure for consumers
James R. Hood
James R. Hood, an editor and consumer-affairs journalist with more than five decades of experience, has held senior editorial leadership roles at The Associated Press, United Press International, Zapnews and ConsumerAffairs.
Money
Bowlers sue Bowlero, alleging private equity–fueled monopoly “destroyed” America’s pastime
The action accuses bowling giant Lucky Strike Entertainment of illegally consolidating the bowling industry, driving up prices and degrading lane quality.
Money
Nike hit with lawsuit over tariff surcharges as consumers demand refunds
The case could become a major test of whether companies that passed tariff costs to consumers must return the money if those tariffs are later invalidated
Health
FDA opens door to flavored vapes, alarming anti-smoking advocates
Public-health groups warn the move could reignite youth vaping after years of declines in teen e-cigarette use
Health
‘Low T’ boom raises concerns over overdiagnosis, aggressive marketing to men
Testosterone prescriptions are surging as private clinics, influencers and social media campaigns promote “low T” as a hidden cause of fatigue, weight gain and low libido
Money
Five squeezes, one wallet: The pressures hitting U.S. consumers this week
American consumers are walking into the second week of May juggling a tighter set of trade-offs than at any point this year.
Money
Court ruling could force IRS to refund pandemic-era late fees to millions
The case is still in court but taxpayers should file a protective refund request now
AI/Privacy
GM to pay $12.75m to settle California claims it sold drivers’ location data to brokers
The company sold data it collected through its OnStar service
Health
Delays in EpiPen Use Drive Fatal Anaphylaxis in Children, New Studies Find
Having a prescription isn't enough. Patients need to have the EpiPen with them.
Lawsuits against GLP-1 drugmakers surge over alleged failure to warn about serious side effects
Thousands of lawsuits have been filed against makers of blockbuster GLP-1 drugs including Ozempic, Wegovy, Mounjaro and Zepbound
Recalls
Safety Recalls May 8, 2026
Take a quick look to see if any apply to you
AI/Privacy
What if you put all the AIs in a room together ...
After 60+ years of hearing complaints about the news, we decided to ask AI about it